Utilization of Nutrient Transporters SLC21A6 (OATP1B1) and SLC21A8 (OATP1B3) as Targets for Cancer Therapy - 1360
- 技術優勢
- Inventionprovides a novel strategy for targeting increased nutrient uptake in cancercells as well as identifies microcystin as an existing toxic substrate withdemonstrated affinity for these particular nutrient transporters.
- 詳細技術說明
- None
- *Abstract
-
None
- 國家/地區
- 美國
欲了解更多信息，請點擊 這裡
